ACCESSION: MSBNK-SMB_Measured-HSA015P0316005
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.03.05 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.05, Curated 2025.03.05)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 16
COMMENT: RAW_SPEC {'EL03_pos_10027': {'bp': 3002786.0, 'sum': 10053166.0}, 'EL03_pos_10141': {'bp': 620104.0, 'sum': 2857664.0}, 'Blanc3-pos_10023': {'bp': 208820.0, 'sum': 747052.0}, 'Blanc2-pos_10006': {'bp': 194512.0, 'sum': 707137.0}, 'EL11_pos_10114': {'bp': 180439.0, 'sum': 647888.0}, 'EL04_pos_10101': {'bp': 176421.0, 'sum': 669140.0}, 'EL14_pos_10137': {'bp': 167378.0, 'sum': 622196.0}, 'EL01_pos_10102': {'bp': 160797.0, 'sum': 611806.0}, 'EL23_pos_10126': {'bp': 158159.0, 'sum': 577973.0}, 'EL18_pos_10113': {'bp': 157739.0, 'sum': 605850.0}, 'EL16_pos_10120': {'bp': 153547.0, 'sum': 546599.0}, 'EL13_pos_10126': {'bp': 149513.0, 'sum': 564058.0}, 'EL20_pos_10123': {'bp': 149409.0, 'sum': 553663.0}, 'EL06_pos_10167': {'bp': 137982.0, 'sum': 521289.0}, 'EL01_pos_10234': {'bp': 104634.0, 'sum': 388519.0}, 'EL11_pos_10235': {'bp': 89652.0, 'sum': 349705.0}}
COMMENT: RETENTION_TIME_STDEV 0.080
COMMENT: PRECURSOR_M/Z_RAW 316.321020
COMMENT: PRECURSOR_M/Z_STDEV 0.000175
COMMENT: PRECURSOR_IN_MS1 mz 316.321011; int 77.064; delta(ppm) 1.301108
COMMENT: PROPOSED_CHARGE_STATE +1; mz 317.324397; int 16.055; cor 0.838
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.013; C19H41NO2; [M+H]+; delta(ppm) 0.012686
COMMENT: PROPOSED_MF MS-FINDER 3.371; C19H41NO2; [M+H]+; delta(ppm) 0.012673
COMMENT: PROPOSED_MF SIRIUS5_Sirius 29.233; C19H41NO2; [M+H]+; delta(ppm) 0.012673
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C19H41NO2; [M+H]+; delta(ppm) 0.012673
COMMENT: PROPOSED_MF SIRIUS6_Sirius 38.307; C19H41NO2; [M+H]+; delta(ppm) 0.012673
COMMENT: PROPOSED_MF SIRIUS6_Sirius 10.574; C17H39N4O; [M+H]+; delta(ppm) 4.257315
COMMENT: PROPOSED_MF SIRIUS6_Sirius 1.572; C15H37N7; [M+H]+; delta(ppm) 8.501993
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C19H41NO2; [M+H]+; delta(ppm) 0.012673
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.627; WFAMPSHDEGZREP-UHFFFAOYNA-N; [M+H]+; CCCCCCCCCCCCCN(CC(C)O)CC(C)O
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.679; WFAMPSHDEGZREP-UHFFFAOYNA-N; [M+H]+; 2-Propanol, 1,1'-(tridecylimino)bis-
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; WFAMPSHDEGZREP-UHFFFAOYNA-N; [M+H]+; 2-Propanol, 1,1'-(tridecylimino)bis-
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.014; BAJLFGHOMLHSCH-IBGZPJMESA-N; [M+H]+; (2S)-2-amino-3-hexadecoxypropan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.984; WFAMPSHDEGZREP-UHFFFAOYSA-N; [M+H]+; 1-[2-hydroxypropyl(tridecyl)amino]propan-2-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -101.201; CMKROKGNOJSPRM; [M+H]+; bis(2-hydroxyethyl)-methyl-tetradecylazanium
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -103.650; WFAMPSHDEGZREP; [M+H]+; 2-Propanol, 1,1''-(tridecylimino)bis-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -106.624; BAJLFGHOMLHSCH; [M+H]+; 1-O-Hexadecyl-2-desoxy-2-amino-sn-glycerol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -135.355; NQDNTSUCOCYXMR; [M+H]+; 3-(Hexadecylamino)propane-1,2-diol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -143.469; LDGWAIFVWDLYCF; [M+H]+; (2-hydroxy-3-tridecoxypropyl)-trimethylazanium
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.174; CMKROKGNOJSPRM; [M+H]+; bis(2-hydroxyethyl)-methyl-tetradecylazanium
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C19H42N1O2; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 Âµm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 16.531
MS$FOCUSED_ION: PRECURSOR_M/Z 316.321010
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-014i-5119000000-b21643806649c4080fe2
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  56.0497365 35.6948 56.050449 0.9634 8.02 0.5893 15 f{C3H6N1}/4.65ppm,p-C16H36O2
  57.0701410 229.4660 57.070858 0.3855 17.03 0.9824 16 f{C4H9}/4.63ppm,p-C15H33N1O2
  58.0653897 26.7726 58.066110 1.1711 4.68 0.8559 16 f{C3H8N1}/4.55ppm,p-C16H34O2
  70.0652661 131.5345 70.066009 0.6565 31.84 0.8118 16 f{C4H8N1}/2.00ppm,p-C15H34O2
  71.0856405 113.1096 71.086384 0.5205 15.71 0.9294 16 f{C5H11}/1.60ppm,p-C14H31N1O2
  74.0601725 31.7079 74.060914 1.5933 5.60 0.7637 13 f{C3H8N1O1}/1.79ppm,p-C16H34O1
  85.1012645 56.5628 85.101976 1.0928 7.47 0.8235 16 f{C6H13}/1.03ppm,p-C13H29N1O2
  88.0757176 353.3859 88.076414 0.3747 98.69 0.7118 16 f{C4H10N1O1}/0.31ppm,p-C15H32O1
  106.0863013 274.6950 106.086854 0.4902 35.34 0.9118 16 f{C4H12N1O2}/0.44ppm,p-C15H30
  118.0863860 24.1013 118.086843 0.8638 5.57 0.7011 14 f{C5H12N1O2}/1.11ppm,p-C14H30
  218.1902984 105.3408 218.190702 0.9900 41.25 0.5059 16 f{C15H24N1}/-0.13ppm,p-C4H18O2
  270.2790633 131.8217 270.279449 1.0175 28.18 0.9500 16 f{C17H36N1O1}/-0.29ppm,p-C2H6O1
  316.3211930 999.0000 316.321613 0.9705 0.00 1.0000 16 f{C19H42N1O2}/0.59ppm,p
  317.3247416 184.5649 317.325162 0.8761 14.60 0.9286 13 ?
  318.3004112 391.6609 318.300833 0.6660 87.15 0.9706 16 ?
PK$NUM_PEAK: 15
PK$PEAK: m/z int. rel.int.
  56.049736 35.69 35
  57.070141 229.47 229
  58.065390 26.77 26
  70.065266 131.53 131
  71.085640 113.11 113
  74.060172 31.71 31
  85.101264 56.56 56
  88.075718 353.39 353
  106.086301 274.69 274
  118.086386 24.10 24
  218.190298 105.34 105
  270.279063 131.82 131
  316.321193 999.00 999
  317.324742 184.56 184
  318.300411 391.66 391
//
